Spirulina: A promising opportunity to overcome neuropathic pain challenges in chronic kidney disease patients [0.03%]
螺旋藻：克服慢性肾脏疾病患者神经病理性疼痛挑战的前景机遇
Zahra Nazari Taloki
Zahra Nazari Taloki
Artificial intelligence-guided nanoparticle design for advanced targeted drug delivery [0.03%]
人工智能指导的纳米颗粒设计在先进靶向药物递送中的应用
Morteza Eskandani
Morteza Eskandani
This editorial aimed to explore the critical role of artificial intelligence (AI) in accurately predicting the structural design of nanoparticles (NPs) during targeted therapy of diseases. Based on experience, it is always surprising that p...
Editorial
BioImpacts : BI. 2025 Dec 1:15:33066. DOI:10.34172/bi.33066 2025
Organoid-engineered neurovascular units for drug discovery and neurodegeneration research [0.03%]
类器官工程神经血管单位在药物发现和神经退行性疾病研究中的应用
Ailar Nakhlband
Ailar Nakhlband
The highly selective permeability of the human blood-brain barrier presents a major obstacle to neurological disease modeling. Established 2D cell cultures and animal models are unable to accurately reproduce the physiological and molecular...
Editorial
BioImpacts : BI. 2025 Dec 9:15:33140. DOI:10.34172/bi.33140 2025
Cell-imprinted substrates as biomimetic platforms for osteoarthritis modeling with mesenchymal stem cells [0.03%]
基于间充质干细胞的骨关节炎类器官模型的细胞印迹基底及其生物模拟平台研究
Hanieh Sadat Hashemi Motahar,Mojtaba Tajbakhsh,Mahboobeh Tavassoli et al.
Hanieh Sadat Hashemi Motahar et al.
Introduction: The objective of this study is twofold: first, to investigate the relationship between chondrocyte morphology and their own gene and protein expression profiles in healthy and osteoarthritic (OA) cartilage; ...
Qian Wang
Qian Wang
Because of its intrinsic tumor heterogeneity, poor response to traditional chemotherapy, and lack of viable molecular targets, liver cancer mostly hepatocellular carcinoma (HCC) continues to be a major worldwide health concern. With a focus...
Correction to: Time dependency of morphological remodeling of endothelial cells in response to substrate stiffness [0.03%]
Correction to: 时间依赖的内皮细胞响应基底刚度在形态重塑方面的研究
Zahra Goli-Malekabadi,Mohammad Tafazzoli-Shadpour,Ali Tamayol et al.
Zahra Goli-Malekabadi et al.
[This corrects the article DOI: 10.15171/bi.2017.06.]. © 2025 The Author(s).
Published Erratum
BioImpacts : BI. 2025 Dec 28:15:32671. DOI:10.34172/bi.32671 2025
Exploring the potential of tubulin-associated unit protein as a biomarker for schizophrenia [0.03%]
探究微管相关单元蛋白作为精神分裂症生物标志物的潜力
Ali Reza Shafiee-Kandjani,Ali Bazzaz Haghighat Talab,Sara Farhang et al.
Ali Reza Shafiee-Kandjani et al.
Introduction: Schizophrenia is a chronic and debilitating psychiatric disease characterized by various causes and symptoms. The tau protein is recognized as a biomarker that plays a crucial role in neurocognitive and neur...
Immune-modulatory biomimetic nanoparticles: Advances in design, mechanisms, and nanomedicine applications [0.03%]
免疫调节仿生纳米颗粒：设计、机制及纳米医学应用研究进展
Somayeh Vandghanooni,Parniya Kehtari,Niloufar Ahdeno
Somayeh Vandghanooni
The development of biomimetic nanoparticles (NPs) represents an innovative approach to address the lacks of conventional drug delivery systems. This advancement demonstrates promising potential in immunotherapy. Biomimetic NPs imitate biolo...
Editorial
BioImpacts : BI. 2025 Dec 10:15:33124. DOI:10.34172/bi.33124 2025
Gold nanoparticle based fluorescent aptasensors: A chemical and biological detection perspective [0.03%]
基于金纳米颗粒的荧光适配子传感器：化学和生物检测视角
Zahra Hashemi,Tayebeh Hashemi,Azam Samadi et al.
Zahra Hashemi et al.
Introduction: In recent decades, the development of simple and reliable techniques for detecting chemical and biological molecules has gained considerable importance. These methods have found extensive applications in dif...
Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance [0.03%]
别构配体驱动的智能纳药共轭物用于选择性靶向突变型EGFR：一种克服酪氨酸激酶抑制剂抗性的精准方法
Dilpreet Singh,Akshay Kumar,Vir Vikram Sharma
Dilpreet Singh
The development of targeted therapies against epidermal growth factor receptor (EGFR) has transformed the clinical management of EGFR-driven malignancies, especially non-small cell lung cancer (NSCLC). However, the therapeutic benefit of AT...